1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow William Bradley: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of EV for Recurrent Endometrial Carcinoma Enfortumab Vedotin - Endometrial Cancer | Phase 2 | Recruiting | William Bradley | 12 | 2026-07-10 | 2026-10-16 |
United States (1)